ONVO Organovo Holdings, Inc.: Rentabilitas operasi

Logo perusahaan publik Organovo Holdings Inc (ONVO)

The operating margin reflects the impact of Organovo Holdings, Inc. (ONVO) extensive investments in 3D bioprinting and metabolism analysis. The stability of live cell express delivery chains and a robust patent shield in cellular engineering create a sustainable market moat. The value of -10293.40 reflects the baseline level of the metric, helping traders identify the true trend of business efficiency without market noise.

Organovo (ONVO): Rentabilitas dodolan operasi saka 04.07.2022 nganti 24.04.2025

Ringkesan rincian data analitis Organovo Holdings, Inc. (ONVO)

- rega lan prakiraan konsensus rega:
Analisis dhasar perusahaan:ONVO, Organovo Holdings, Inc.
Produk dadi Organovo Corp

Sales of innovative 3D bioprinting tissue technologies for pharmaceutical R&D centers generate revenue for Organovo Holdings, Inc. (ONVO), the management efficiency of which is reflected in the operating margin. This core business profitability metric demonstrates the share of profit before taxes and interest, allowing investors to assess the business's ability to generate cash flow from operating processes independently of debt load and tax regimes.